Eversheds Sutherland advises Pacira BioSciences, Inc., on its acquisition of GQ Bio Therapeutics
March 03, 2025
Eversheds Sutherland advises Pacira BioSciences, Inc., on its acquisition of GQ Bio TherapeuticsMarch 03, 2025 Eversheds Sutherland has advised NASDAQ listed Pacira BioSciences, Inc., on its acquisition of the remaining 81 percent equity stake of GQ Bio Therapeutics GmbH. Formats the Html codes.FormatFix the Html to be XHtml compliantFix
Write
Validate that the text is XHtml compliant.Validate
Proofing
Eversheds Sutherland advised Pacira BioSciences on the German law aspects of the transaction. Pacira acquired the outstanding stake in GQ Bio from the founders and venture capital investors like High-Tech Gründerfonds and IFB Innovationsstarter GmbH. This transaction builds upon Pacira’s previous investments in GQ Bio, as well as the two companies’ partnership for the development of a commercially scalable manufacturing process for PCRX-201 (enekinragene inzadenovec) and other products utilizing GQ Bio’s high-capacity adenovirus, or HCAd, gene therapy vector platform. GQ Bio is a privately held biopharmaceutical company with a novel, high-capacity, local-delivery platform that makes genetic medicines more efficient and enables the use of large and multiple gene constructs. GQ Bio also brings to Pacira a preclinical portfolio of assets with disease-modifying potential in prevalent musculoskeletal diseases, and research and development talent. The Eversheds Sutherland team was co-led by Partners Robin Johnson in the UK, Dr. Christian Mense and Dr. Christian Lindner in Germany. Latest News
Latest Events
deal alerts November 06, 2026 Eversheds Sutherland advises Mercedes-Benz on European fast-charging partne... firm news November 05, 2026 Eversheds Sutherland hires partner Peter Cheng to lead Hong Kong ECM practi... firm news October 27, 2026 Eversheds Sutherland (International) announces senior leadership appointmen... firm news October 26, 2026 Eversheds Sutherland deepens fintech and regulatory bench with double partn... hybrid Europe Action Week 2026 Europe Action Week returns this November with a dynamic mix of events designed to help you navigate what’s next. virtual Belgian employment law training November 17, 2026 2.00pm - 5.00pm (GMT) Virtual in-person Industrial relations masterclass November 18, 2026 9.30am - 4.30pm (GMT) London, United Kingdom virtual Immigration UK Business – sponsor licencing course November 24, 2026 9.30am - 11.30am (GMT) Virtual |